Soleus Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$687K Buy
+10,000
New +$568K 0.02% 90
2025
Q3
Sell
-40,000
Closed -$3.69M 111
2025
Q2
$3.69M Buy
+40,000
New +$3.14M 0.24% 65
2025
Q1
Sell
-4,000
Closed -$307K 96
2024
Q4
$307K Buy
+4,000
New +$279K 0.02% 77
2024
Q3
Sell
-87,000
Closed -$2.27M 107
2024
Q2
$2.27M Sell
87,000
-696,376
-89% -$13.2M 0.2% 78
2024
Q1
$7.15M Buy
783,376
+723,376
+1,206% +$4.34M 0.53% 53
2023
Q4
$165K Sell
60,000
-721,396
-92% -$1.68M 0.02% 71
2023
Q3
$2.84M Buy
781,396
+70,000
+10% +$384K 0.26% 64
2023
Q2
$4.24M Buy
711,396
+167,760
+31% +$1.33M 0.47% 54
2023
Q1
$6.55M Buy
+543,636
New +$7.25M 0.68% 42

Other funds holding WGS

Soleus Capital Management's WGS Position: Q2 2026 in Review

Soleus Capital Management opened a new position in GeneDx Holdings (WGS) in Q2 2026: 10,000 shares worth $687K. The stake represents 0.02% of the portfolio and ranks #90 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in WGS as recently as Q2 2025.

Soleus Capital Management first reported a position in WGS in Q1 2023 and has held it in 9 quarters since. The position peaked at $7.15M in Q1 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Soleus Capital Management held 10,000 shares of GeneDx Holdings worth $687K as of Q2 2026.
  • GeneDx Holdings was a new Soleus Capital Management position in Q2 2026.
  • GeneDx Holdings made up 0.02% of Soleus Capital Management's portfolio in Q2 2026, its #90 holding.
  • Soleus Capital Management first reported a position in GeneDx Holdings in Q1 2023 and has held it in 9 quarters since.
  • Soleus Capital Management's GeneDx Holdings position peaked at $7.15M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.